Phibro Animal Health Corp PAHC
We take great care to ensure that the data presented and summarized in this overview for PHIBRO ANIMAL HEALTH CORP is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding PAHC
View all-
Black Rock Inc. New York, NY3.5MShares$81.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.49MShares$34.7 Million0.0% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA1.48MShares$34.5 Million0.4% of portfolio
-
Richard Pzena Pzena Investment Management LLC1.46MShares$33.9 Million0.11% of portfolio
-
State Street Corp Boston, MA905KShares$21 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX778KShares$18.1 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA718KShares$16.7 Million0.05% of portfolio
-
Parkwood LLC Cleveland, OH554KShares$12.9 Million0.88% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny547KShares$12.7 Million0.02% of portfolio
-
American Century Companies Inc Kansas City, MO539KShares$12.5 Million0.01% of portfolio
Latest Institutional Activity in PAHC
Top Purchases
Top Sells
About PAHC
Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for poultry, swine, beef and dairy cattle, aquaculture, and dogs. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. The company also offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. In addition, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. It operates in the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.
Insider Transactions at PAHC
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 04
2024
|
E Thomas Corcoran Director |
BUY
Open market or private purchase
|
Direct |
5,000
+16.67%
|
$100,000
$20.02 P/Share
|
Aug 30
2021
|
E Thomas Corcoran Director |
BUY
Open market or private purchase
|
Direct |
5,000
+20.0%
|
$115,000
$23.68 P/Share
|
Feb 09
2021
|
Larry Lee Miller Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
20,000
-40.0%
|
$440,000
$22.94 P/Share
|
Feb 08
2021
|
Larry Lee Miller Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+50.0%
|
-
|
Last 12 Months Summary
Open market or private purchase | 5K shares |
---|